Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity

Biomedicine and Pharmacotherapy

Volumn 90, Issue , 2017, Pages 935-946

  Abushouk, Abdelrahman Ibrahim ^a,b   Ismail, Ammar ^b,c   Salem, Amr Muhammad Abdo ^a,b   Afifi, Ahmed M ^a   Abdel Daim, Mohamed M ^d,e  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b NovaMed Medical research Association   (Egypt)

^c AL AZHAR UNIVERSITY   (Egypt)

^d Suez Canal University   (Egypt)

^e HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

Cardioprotection; Doxorubicin; Phytochemicals; Toxicity

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; DOXORUBICIN; PLANT MEDICINAL PRODUCT; PROTECTIVE AGENT; PHYTOCHEMICAL;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CARDIOTOXICITY; CLINICAL PRACTICE; CLINICAL RESEARCH; DRUG MECHANISM; HEART PROTECTION; HUMAN; NONHUMAN; PRECLINICAL STUDY; PRIORITY JOURNAL; REVIEW; SURVIVAL; ANIMAL; DRUG EFFECTS; HEART;

ANIMALS; CARDIOTOXICITY; DOXORUBICIN; HEART; HUMANS; PHYTOCHEMICALS; PROTECTIVE AGENTS;

EID: 85018726911     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.04.033     Document Type: Review

References (164)

1. [1] Arcamone, F., Cassinelli, G., Fantini, G., et al. Adriamycin, 14-hydroxydaimomycin, a new antitumor antibiotic from S. peucetius var. caesius. Biotechnol. Bioeng. 11 (1969), 1101–1110.
2. [2] Tacar, O., Sriamornsak, P., Dass, C.R., Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J. Pharm. Pharmacol. 65 (2013), 157–170.
3. [3] Chatterjee, K., Zhang, J., Honbo, N., Karliner, J.S., Doxorubicin cardiomyopathy. Cardiology 115 (2010), 155–162.
4. [4] Lefrak, E., Piťha, J., Rosenheim, S., Gottlieb, J., A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32 (1973), 302–314.
5. [5] Takemura, G., Fujiwara, H., Doxorubicin-induced cardiomyopathy: from the cardiotoxic mechanisms to management. Prog. Cardiovasc. Dis. 49 (2007), 330–352.
6. [6] Swain, S., Whaley, F., Ewer, M., Congestive heart failure in patients treated with doxorubicin. Cancer 97 (2003), 2869–2879.
7. [7] Koul, A., Goyal, R., Bharati, S., Protective effect of Azadirachta indica A. Juss against doxorubicin-induced cardiac toxicity in tumour bearing mice. Indian J. Exp. Biol. 52 (2014), 323–331.
8. [8] Von Hoff, Daniel D., Layard, Maxwell W., Basa, P., Davis, Hugh L., Von Hoff, Ann L., Rozencweig, Marcel, Muggia, Franco M., Risk factors for doxorubicin-induced congestive heart failure. Ann. Intern. Med. 91 (1979), 710–717.
9. [9] Bernstein, D., Fajardo, G., Zhao, M., et al. Differential cardioprotective/cardiotoxic effects mediated by β-adrenergic receptor subtypes. Am. J. Physiol. Heart Circ. Physiol. 289 (2005), H2441–H2449.
10. [10] Lipshultz, S.E., Alvarez, J.A., Scully, R.E., Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart (British Cardiac Society) 94 (2008), 525–533.
11. [11] Kim, S.Y., Kim, S.-J., Kim, B.-J., et al. Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in rat cardiomyocytes. Exp. Mol. Med. 38 (2006), 535–545.
12. [12] Myers, C., The role of iron in doxorubicin-induced cardiomyopathy. Seminars in Oncology 25:Suppl. 10 (4) (1998), 10–14.
13. [13] Ghibu, S., Delemasure, S., Richard, C., et al. General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid. Biochimie 94 (2012), 932–939.
14. [14] Troyano, A., Fernández, C., Sancho, P., et al. Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells. The role of intracellular oxidation. J. Biol. Chem. 276 (2001), 47107–47115.
15. [15] Mimnaugh, E.G., Trush, M.A., Bhatnagar, M., Gram, T.E., Enhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycin. Biochem. Pharmacol. 34 (1985), 847–856.
16. [16] Doroshow, J.H., Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Res. 43 (1983), 460–472.
17. [17] Ishibashi, Y., Takahashi, N., Tokumaru, A., et al. Activation of inducible NOS in peripheral vessels and outcomes in heart failure patients. J. Card. Fail. 14 (2008), 724–731.
18. [18] Schildknecht, S., Pape, R., Müller, N., et al. Neuroprotection by minocycline caused by direct and specific scavenging of peroxynitrite. J. Biol. Chem. 286 (2011), 4991–5002.
19. [19] Barry, E., Alvarez, J., Scully, R., Miller, T., Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opin. Pharmacother. 8 (2007), 1039–1058.
20. [20] Alkreathy, H.M., Damanhouri, Z.A., Ahmed, N., et al. Mechanisms of cardioprotective effect of aged garlic extract against doxorubicin-induced cardiotoxicity. Integr. Cancer Ther. 11 (2012), 364–370.
21. [21] Chen, B., Peng, X., Pentassuglia, L., et al. Molecular and cellular mechanisms of anthracycline cardiotoxicity. Cardiovasc. Toxicol. 7 (2007), 114–121.
22. [22] Monti, E., Prosperi, E., Supino, R., Bottiroli, G., Free radical-dependent DNA lesions are involved in the delayed cardiotoxicity induced by adriamycin in the rat. Anticancer Res. 15 (1995), 193–197.
23. [23] Papaiahgari, S., Zhang, Q., Kleeberger, S.R., et al. Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells. Antioxid. Redox Signal. 8 (2006), 43–52.
24. [24] El Hassan, M.A.I.A., Verheul, H.M.W., Jorna, A.S., et al. The new cardioprotector monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro. Br. J. Cancer 89 (2003), 357–362.
25. [25] Mantawy, E.M., El-Bakly, W.M., Esmat, A., et al. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Eur. J. Pharmacol. 728 (2014), 107–118.
26. [26] Arafa, M.H., Mohammad, N.S., Atteia, H.H., Abd-Elaziz, H.R., Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats. J. Physiol. Biochem. 70 (2014), 701–711.
27. [27] Wang, B., Hao, J., Jones, S.C., et al. Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart. Am. J. Physiol. Heart Circ. Physiol. 282 (2002), H1685–H1696.
28. [28] Kang, Y.J., Cardiac hypertrophy: a risk factor for QT-prolongation and cardiac sudden death. Toxicol. Pathol. 34 (2006), 58–66.
29. [29] Viero, R.M., Soares, V.A., The hemolytic uremic syndrome as a complication of adriamycin nephropathy. Ren. Fail. 20 (1998), 565–571.
30. [30] Abdel-aleem, S., El-Merzabani, M.M., Sayed-Ahmed, M., et al. Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes. J. Mol. Cell. Cardiol. 29 (1997), 789–797.
31. [31] Minotti, G., Mancuso, C., Frustaci, A., Mordente, A., Santini, S.A., Calafiore, A.M., Liberi, G., Gentiloni, N., Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity. J. Clin. Invest., 98(3), 1996, 650.
32. [32] Thayer, W.S., Decreased cardiac lipoprotein lipase activity in rats treated chronically with adriamycin. Life Sci. 36:7 (1985), 635–641.
33. [33] Singal, P.K., Panagia, V., Direct effects of adriamycin on the rat heart sarcolemma. Res. Commun. Chem. Pathol. Pharmacol. 43 (1984), 67–77.
34. [34] Tong, J., Ganguly, P.K., Singal, P.K., Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats. Am. J. Physiol. Heart Circ. Physiol. 260 (1991), H909–H916.
35. [35] Andrieu-abadie, N., JaffrÉzou, J., Hatem, S., et al. L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation. FASEB J. 13 (1999), 1501–1510.
36. [36] Kurabayashi, M., Jeyaseelan, R., Kedes, L., Doxorubicin represses the function of the myogenic helix-loop-helix transcription factor MyoD. Involvement of Id gene induction. J. Biol. Chem. 269 (1994), 6031–6039.
37. [37] Meadowcroft, A.M., Gilbert, C.J., Maravich-May, D., Hayward, S.L., Cost of managing anemia with and without prophylactic epoetin alfa therapy in breast cancer patients receiving combination chemotherapy. Am. J. Health Syst. Pharm. 55 (1998), 1898–1902.
38. [38] Carvalho, C., Santos, R.X., Cardoso, S., et al. Doxorubicin: the good, the bad and the ugly effect. Curr. Med. Chem. 16 (2009), 3267–3285.
39. [39] Seifert, C.F., Nesser, M.E., Thompson, D.F., Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity. Ann. Pharmacother. 28 (1994), 1063–1072.
40. [40] Pavlova, V., Sainova, I., Alexieva, B., et al. Antioxidant effect of aronia melanocarpa extract after doxorubicin abstract. Bulg. J. Agric. Sci. 20 (2014), 188–192.
41. [41] Cao, Y., Ruan, Y., Shen, T., et al. Astragalus polysaccharide suppresses doxorubicin-induced cardiotoxicity by regulating the PI3k/Akt and p38MAPK pathways. Oxid. Med. Cell. Longev., 2014, 2014, 674219.
42. [42] Chang, W.T., Li, J., Haung, H.H., et al. Baicalein protects against doxorubicin-induced cardiotoxicity by attenuation of mitochondrial oxidant injury and JNK activation. J. Cell. Biochem. 112 (2011), 2873–2881.
43. [43] Uma Mahesh, B., Shrivastava, S., Kuncha, M., et al. Ethanolic extract of Boswellia ovalifoliolata bark and leaf attenuates doxorubicin-induced cardiotoxicity in mice. Environ. Toxicol. Pharmacol. 36 (2013), 840–849.
44. [44] El-Boghdady, N.A., Increased cardiac endothelin-1 and nitric oxide in adriamycin-induced acute cardiotoxicity: protective effect of Ginkgo biloba extract. Indian J. Biochem. Biophys. 50 (2013), 200–209.
45. [45] Mokni, M., Hamlaoui-Guesmi, S., Amri, M., et al. Grape seed and skin extract protects against acute chemotherapy toxicity induced by doxorubicin in rat heart. Cardiovasc. Toxicol. 12 (2012), 158–165.
46. [46] Ragavendran, P., Sophia, D., Arulraj, C., Gopalakrishnan, V.K., Cardioprotective effect of aqueous, ethanol and aqueous ethanol extract of Aerva lanata (Linn.) against doxorubicin induced cardiomyopathy in rats. Asian Pac. J. Trop. Biomed. 2 (2012), S212–S218.
47. [47] Khan, M.S., Singh, M., Khan, M.A., et al. Scientific validation of cardioprotective attribute by standardized extract of Bombyx mori against doxorubicin-induced cardiotoxicity in murine model. EXCLI J. 13 (2014), 1043–1054.
48. [48] Ojha, S., Al Taee, H., Goyal, S., et al. Cardioprotective potentials of plant-derived small molecules against doxorubicin associated cardiotoxicity. Oxid. Med. Cell. Longev., 2016, 2016, 5724973.
49. [49] Kok, L.D., Wong, Y.P., Wu, T.W., et al. Morin hydrate: a potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by anti-tumor drugs. Life Sci. 67 (2000), 91–99.
50. [50] Mukherjee, S., Banerjee, S.K., Maulik, M., et al. Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-alpha expression. BMC Pharmacol., 3, 2003, 16.
51. [51] Alkreathy, H., Damanhouri, Z.A., Ahmed, N., et al. Aged garlic extract protects against doxorubicin-induced cardiotoxicity in rats. Food Chem. Toxicol. 48 (2010), 951–956.
52. [52] Demirkaya, E., Avci, A., Kesik, V., et al. Cardioprotective roles of aged garlic extract, grape seed proanthocyanidin, and hazelnut on doxorubicin-induced cardiotoxicity. Can. J. Physiol. Pharmacol. 87 (2009), 633–640.
53. [53] Kaithwas, G., Dubey, K., Pillai, K.K., Effect of Aloe vera (Aloe barbadensis Miller) gel on doxorubicin-induced myocardial oxidative stress and calcium overload in albino rats. Indian J. Exp. Biol. 49 (2011), 260–268.
54. [54] Kaithwas, G., Singh, P., Bhatia, D., Evaluation of in vitro and in vivo antioxidant potential of polysaccharides from Aloe vera (Aloe barbadensis Miller) gel. Drug Chem. Toxicol. 37 (2014), 135–143.
55. [55] Jagetia, G.C., Reddy, T.K., Malagi, K.J., et al. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its antineoplastic activity. Phytother. Res. PTR 19 (2005), 772–778.
56. [56] Pavlova, V., Sainova, I., Alexieva, B., Valkova, I., Markova, T.z., Nikolova, E., Antioxidant effect of Aronia melanocarpa extract after doxorubicin treatment. Bulg. J. Agric. Sci. 20 (2014), 188–192.
57. [57] Singh, G., Singh, A.T., Abraham, A., et al. Protective effects of Terminalia arjuna against doxorubicin-induced cardiotoxicity. J. Ethnopharmacol. 117 (2008), 123–129.
58. [58] Wang, S.Q., Zhu, X.-F., Wang, X.-N., et al. Flavonoids from Malus hupehensis and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells. Phytochemistry 87 (2013), 119–125.
59. [59] Patel, S.S., Verma, N.K., Rathore, B., et al. Cardioprotective effect of Bombax ceiba flowers against acute adriamycin-induced myocardial infarction in rats. Revista Brasileira de Farmacognosia 21 (2011), 704–709.
60. [60] Ashour, O.M., Abdel-Naim, A.B., Abdallah, H.M., et al. Evaluation of the potential cardioprotective activity of some Saudi plants against doxorubicin toxicity. Z. Naturforsch. 67 (2012), 297–307.
61. [61] Kim, D.S., Kim, H.-R., Woo, E.-R., et al. Protective effect of calceolarioside on adriamycin-induced cardiomyocyte toxicity. Eur. J. Pharmacol. 541 (2006), 24–32.
62. [62] Fouad, A.A., Albuali, W.H., Al-Mulhim, A.S., Jresat, I., Cardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicity. Environ. Toxicol. Pharmacol. 36 (2013), 347–357.
63. [63] Hao, E., Mukhopadhyay, P., Cannabidiol protects against doxorubicin-induced cardiomyopathy by modulating mitochondrial function and biogenesis. Mol. Med., 21, 2015, 1.
64. [64] Nair, C.K., Indu, R., Azhar, T., Nair, A., Amelioration of doxorubicin induced cardio-and hepato-toxicity by carotenoids. J. Cancer Res. Ther., 10, 2014, 62.
65. [65] Liu, Z., Song, X., Xin, Y., et al. Protective effect of chrysoeriol against doxorubicin-induced cardiotoxicity in vitro. Chin. Med. J. 122 (2009), 2652–2656.
66. [66] Putri, H., Nagadi, S., Larasati, Y.A., et al. Cardioprotective and hepatoprotective effects of Citrus hystrix peels extract on rats model. Asian Pac. J. Trop. Biomed. 3 (2013), 371–375.
67. [67] Elberry, A.A., Abdel-Naim, A.B., Abdel-Sattar, E.A., et al. Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats. Food Chem. Toxicol. 48 (2010), 1178–1184.
68. [68] Chen, C.T., Wang, Z.-H., Hsu, C.-C., et al. In vivo protective effects of diosgenin against doxorubicin-induced cardiotoxicity. Nutrients 7 (2015), 4938–4954.
69. [69] Shah, S.A., Mohan, M.M.A., Kasture, S.A., Sanna, C.B., Maxia, A., Protective effect of Ephedra nebrodensis on doxorubicin-induced cardiotoxicity in rats. Iran. J. Pharmacol. Ther. 8 (2009), 61–66.
70. [70] Fouad, A.A., Yacoubi, M.T., Mechanisms underlying the protective effect of eugenol in rats with acute doxorubicin cardiotoxicity. Arch. Pharm. Res. 34 (2011), 821–828.
71. [71] Palani, S., Jayakumar, M., Karthi, S., Raja, S., Protective effects of Flacourtia indica on doxorubicin-induced cardiotoxicity in rats. Toxicol. Environ. Chem. 94 (2012), 1014–1025.
72. [72] Van Acker, S.A., Boven, E., Kuiper, K., et al. Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin. Clin. Cancer Res. 3 (1997), 1747–1754.
73. [73] Van Acker, F.A., van Acker, S.A., Kramer, K., et al. 7-Monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week. Clin. Cancer Res. 6 (2000), 1337–1341.
74. [74] Van Acker, F.A., Boven, E., Kramer, K., et al. Frederine, a new and promising protector against doxorubicin-induced cardiotoxicity. Clin. Cancer Res. 7 (2001), 1378–1384.
75. [75] Mandziuk, S., Gieroba, R., Korga, A., et al. The differential effects of green tea on dose-dependent doxorubicin toxicity. Food Nutr. Res., 59, 2015, 29754.
76. [76] Li, W., Nie, S., Xie, M., et al. A major green tea component, (−)-epigallocatechin-3-gallate, ameliorates doxorubicin-mediated cardiotoxicity in cardiomyocytes of neonatal rats. J. Agric. Food Chem. 58 (2010), 8977–8982.
77. [77] Khan, G., Haque, S.E., Anwer, T., Ahsan, M.N., Safhi, M.M., Alam, M.F., Cardioprotective effect of green tea extract on doxorubicin-induced cardiotoxicity in rats. Acta Poloniae Pharm. Drug Res. 71 (2014), 861–868.
78. [78] Wahiba, K.A., Safia, I., Nacira, A., The combination therapy of medicinal plant globularia alypum, with adriamycin limits free radical mediated cardiac injury in rats. Int. J. Pharm. Sci. Rev. Res. 36 (2016), 1–8.
79. [79] Zarei, M., Javarappa, K.K., Zarei, M., Baker, S., Cardioprotective effect of the root extract of Hemidesmus indicus against doxorubicin—induced oxidative stress in mice. Der Pharm. Lett. 5 (2013), 334–339.
80. [80] Khedr, N.F., Khalil, R.M., Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin. Tumor Biol. 36 (2015), 9267–9275.
81. [81] Trivedi, P.P., Kushwaha, S., Tripathi, D.N., Jena, G.B., Cardioprotective effects of hesperetin against doxorubicin-induced oxidative stress and DNA damage in rat. Cardiovasc. Toxicol. 11 (2011), 215–225.
82. [82] Shah, S., Mohan, M., Kasture, S., et al. Protective effect of Hypericum hircinum on doxorubicin-induced cardiotoxicity in rats. Nat. Prod. Res. 27 (2013), 1502–1507.
83. [83] Adwas, A.A., Elkhoely, A.A., Kabel, A.M., et al. Anti-cancer and cardioprotective effects of indol-3-carbinol in doxorubicin-treated mice. J. Infect. Chemother. 22 (2016), 36–43.
84. [84] Nazmi, A.S., Ahmad, S.J., Rashikh, A., et al. Protective effects of “Khamira Abresham Hakim Arshad Wala”, a unani formulation against doxorubicin-induced cardiotoxicity and nephrotoxicity. Toxicol. Mech. Methods 21 (2011), 41–47.
85. [85] Singh, M.K., Mohd, F., Ayaz, A., Ankur, S., Jyoti, Y., Protective effect of lagenaria siceraria against doxorubicin induced cardiotoxicity in wistar rats. Int. J. Drug Dev. Res. 4 (2012), 298–305.
86. [86] Fard, M.H., Bodhankar, S.L., Dikshit, M., Cardioprotective activity of fruit of Lagenaria siceraria (Molina) standley on doxorubicin induced cardiotoxicity in rats. Int. J. Pharmacol. 4 (2008), 466–471.
87. [87] Koti, B.C., Vishwanathswamy, A.H.M., Wagawade, J., Thippeswamy, A.H.M., Cardioprotective effect of lipistat against doxorubicin induced myocardial toxicity in albino rats. Indian J. Exp. Biol. 47 (2009), 41–46.
88. [88] Xin, Y.F., Zhou, G.-L., Deng, Z.-Y., et al. Protective effect of Lycium barbarum on doxorubicin-induced cardiotoxicity. Phytother. Res. PTR 21 (2007), 1020–1024.
89. [89] Xin, Y.F., Wan, L.-L., Peng, J.-L., Guo, C., Alleviation of the acute doxorubicin-induced cardiotoxicity by Lycium barbarum polysaccharides through the suppression of oxidative stress. Food Chem. Toxicol. 49 (2011), 259–264.
90. [90] Karimi, G., Ramezani, M., Abdi, A., Protective effects of lycopene and tomato extract against doxorubicin-induced cardiotoxicity. Phytother. Res. PTR 19 (2005), 912–914.
91. [91] Arozal, W., Suyatna, F.D., Juniantito, V., et al. The effects of Mangiferin (Mangifera indica L). in doxorubicin-induced cardiotoxicity in rats. Drug Res. 65 (2015), 574–580.
92. [92] Han, X., Pan, J., Ren, D., et al. Naringenin-7-O-glucoside protects against doxorubicin-induced toxicity in H9c2 cardiomyocytes by induction of endogenous antioxidant enzymes. Food Chem. Toxicol. 46 (2008), 3140–3146.
93. [93] Li, M., Wang, X., Zheng, X., et al. A new ionone glycoside and three new rhemaneolignans from the roots of Rehmannia glutinosa. Molecules (Basel, Switzerland) 20 (2015), 15192–15201.
94. [94] Han, X., Protective effect of naringenin-7-O-glucoside against oxidative stress induced by doxorubicin in H9c2 cardiomyocytes. BioSci. Trends 6 (2012), 19–25.
95. [95] Andreadou, I., Sigala, F., Iliodromitis, E.K., et al. Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress. J. Mol. Cell. Cardiol. 42 (2007), 549–558.
96. [96] Alpsoy, S., Aktas, C., Uygur, R., et al. Antioxidant and anti-apoptotic effects of onion (Allium cepa) extract on doxorubicin-induced cardiotoxicity in rats. J. Appl. Toxicol. JAT 33 (2013), 202–208.
97. [97] Kumral, A., Giriş, M., Soluk-Tekkeşin, M., et al. Effect of olive leaf extract treatment on doxorubicin-induced cardiac, hepatic and renal toxicity in rats. Pathophysiology 22 (2015), 117–123.
98. [98] Abdel-Wahab, M.H., El-Mahdy, M.A., Abd-Ellah, M.F., et al. Influence of p-coumaric acid on doxorubicin-induced oxidative stress in rat's heart. Pharmacol. Res. 48 (2003), 461–465.
99. [99] Miranda-Vilela, A.L., Grisolia, C.K., Longo, J.P.F., et al. Oil rich in carotenoids instead of vitamins C and E as a better option to reduce doxorubicin-induced damage to normal cells of Ehrlich tumor-bearing mice: hematological, toxicological and histopathological evaluations. J. Nutr. Biochem. 25 (2014), 1161–1176.
100. [100] Komolafe, K., Akinmoladun, A.C., Olaleye, T.M., Methanolic leaf extract of Parkia biglobosa protects against doxorubicin-induced cardiotoxicity in rats. Int. J. Appl. Res. Nat. Prod. 6 (2013), 39–47.
101. [101] Fard, M.H., Ghule, A.E., Bodhankar, S.L., Dikshit, M., Cardioprotective effect of whole fruit extract of pomegranate on doxorubicin-induced toxicity in rat. Pharm. Biol. 49 (2011), 377–382.
102. [102] Li, W., Xu, B., Xu, J., Wu, X.-L., Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress. Basic Clin. Pharmacol. Toxicol. 104 (2009), 192–197.
103. [103] Dutta, D., Dutta, D., Xu, J., et al. Calorie restriction combined with resveratrol induces autophagy and protects 26-month-old rat hearts from doxorubicin-induced toxicity. Free Radic. Biol. Med. 74 (2014), 252–262.
104. [104] Janeesh, P.A., Abraham, A., Robinin modulates doxorubicin-induced cardiac apoptosis by TGF-β1 signaling pathway in Sprague Dawley rats. Biomed. Pharmacother. 68 (2014), 989–998.
105. [105] Chahine, N., Hanna, J., Makhlouf, H., et al. Protective effect of saffron extract against doxorubicin cardiotoxicity in isolated rabbit heart. Pharm. Biol. 51 (2013), 1564–1571.
106. [106] Chahine, N., Makhlouf, H., Duca, L., et al. Cardioprotective effect of saffron extracts against acute doxorubicin toxicity in isolated rabbit hearts submitted to ischemia-reperfusion injury. Z. Naturforsch. J. Biosci. 69 (2014), 459–470.
107. [107] Aniss, H.A., Said, A.E.M., El Sayed, I.H., Adly, C., Amelioration of adriamycin-induced cardiotoxicity by Salsola kali aqueous extract is mediated by lowering oxidative stress. Redox Rep. Commun. Free Radic. Res. 19 (2014), 170–178.
108. [108] Kamble, S., Mohan, M., Kasture, S., Protective effect of solanum torvum on doxorubicin-induced cardiactoxicity in rats. Food Chem. Toxicol. 48 (2009), 436–440.
109. [109] Lin, T.J., Liu, G.T., Liu, Y., Xu, G.Z., Protection by salvianolic acid A against adriamycin toxicity on rat heart mitochondria. Free Radic. Biol. Med. 12 (1992), 347–351.
110. [110] Jiang, B., Zhang, L., Li, M., et al. Salvianolic acids prevent acute doxorubicin cardiotoxicity in mice through suppression of oxidative stress. Food Chem. Toxicol. 46 (2008), 1510–1515.
111. [111] Su, S., Li, Q., Liu, Y., et al. Sesamin ameliorates doxorubicin-induced cardiotoxicity: involvement of Sirt1 and Mn-SOD pathway. Toxicol. Lett. 224 (2014), 257–263.
112. [112] Chennuru, A., Saleem, M.T.S., Antioxidant, lipid lowering, and membrane stabilization effect of sesamol against doxorubicin-induced cardiomyopathy in experimental rats. BioMed Res. Int. 2013 (2013), 1–5.
113. [113] Chlopcíková, S., Psotová, J., Miketová, P., et al. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part II. caffeic, chlorogenic and rosmarinic acids. Phytother. Res. PTR 18 (2004), 408–413.
114. [114] Chlopcíková, S., Psotová, J., Miketová, P., Simánek, V., Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans. Phytother. Res. PTR 18 (2004), 107–110.
115. [115] Rašković, A., Stilinović, N., Kolarović, J., et al. The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. Molecules (Basel, Switzerland) 16 (2011), 8601–8613.
116. [116] Sakthivel, K., Palani, S., Selvaraj, R., Venkadesan, D., Sivasankari, H., Kumar, B.S., Cardioprotective and antioxidant potential of Scilla hyacinthina. J. Biol. Sci. 13 (2013), 313–322.
117. [117] Breitbart, E., Lomnitski, L., Nyska, A., et al. Effects of water-soluble antioxidant from spinach, NAO, on doxorubicin-induced heart injury. Hum. Exp. Toxicol. 20 (2001), 337–345.
118. [118] Zhang, S., Wang, W., Wang, J., Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo. Acta Pharmacol. Sin. 30 (2009), 1479–1487.
119. [119] Al-Shabanah, O.A., Badary, O.A., Nagi, M.N., et al Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. J. Exp. Clin. Cancer Res. CR 17 (1998), 193–198.
120. [120] Nagi, M.N., Mansour, M.A., Protective effect of thymoquinone against doxorubicin–induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol. Res. 41 (2000), 283–289.
121. [121] Koti, B.C., Nagathan, S., Vishwanathswamy, A., et al. Cardioprotective effect of Vedic Guard against doxorubicin-induced cardiotoxicity in rats: a biochemical, electrocardiographic, and histopathological study. Pharmacognosy Mag. 9 (2013), 176–181.
122. [122] Hamza, A., Amin, A., Daoud, S., The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats. Cell Biol. Toxicol. 24 (2008), 63–73.
123. [123] Arafa, H.M., Abd-Ellah, M.F., Hafez, H.F., Abatement by naringenin of doxorubicin-induced cardiac toxicity in rats. J. Egypt. Natl. Cancer Inst. 17 (2005), 291–300.
124. [124] Xin, Y.F., Zhou, G.-L., Shen, M., et al. Angelica sinensis: a novel adjunct to prevent doxorubicin-induced chronic cardiotoxicity. Basic Clin. Pharmacol. Toxicol. 101 (2007), 421–426.
125. [125] Psotová, J., Chlopcíková, S., Miketová, P., Simánek, V., Cytoprotectivity of Prunella vulgaris on doxorubicin-treated rat cardiomyocytes. Fitoterapia 76 (2005), 556–561.
126. [126] Sun, J., Sun, G., Meng, X., et al. Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. PLoS One, 8, 2013, e64526.
127. [127] You, J.S., Pan, T.-L., Lee, Y.-S., Protective effects of Danshen (Salvia miltiorrhiza) on adriamycin-induced cardiac and hepatic toxicity in rats. Phytother. Res. PTR 21 (2007), 1146–1152.
128. [128] Nagai, K., Konishi, H., Protection of theanine against doxorubicin-induced acute cardiac toxicity. Biomed. Prev. Nutr. 3 (2013), 197–199.
129. [129] Chularojmontri, L., Wattanapitayakul, S.K., Herunsalee, A., et al. Antioxidative and cardioprotective effects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity. Biol. Pharm. Bull. 28 (2005), 1165–1171.
130. [130] Gnanapragasam, A., Yogeeta, S., Subhashini, R., et al. Adriamycin induced myocardial failure in rats: protective role of Centella asiatica. Mol. Cell. Biochem. 294 (2007), 55–63.
131. [131] Chang, W.T., Li, J., Haung, H.-H., et al. Baicalein protects against doxorubicin-induced cardiotoxicity by attenuation of mitochondrial oxidant injury and JNK activation. J. Cell. Biochem. 112 (2011), 2873–2881.
132. [132] Choi, H.J., Seon, M.R., Lim, S.S., et al. Hexane/ethanol extract of Glycyrrhiza uralensis licorice suppresses doxorubicin-induced apoptosis in H9c2 rat cardiac myoblasts. Exp. Biol. Med. (Maywood, NJ) 233 (2008), 1554–1560.
133. [133] Chen, R.C., Xu, X.D., Zhi Liu, X., et al. Total flavonoids from Clinopodium chinense (Benth.) O. Ktze protect against doxorubicin-induced cardiotoxicity in vitro and in vivo. Evid. Based Complement. Altern. Med. eCAM, 2015, 2015, 472565.
134. [134] Chatterjee, K., Zhang, J., Tao, R., et al. Vincristine attenuates doxorubicin cardiotoxicity. Biochem. Biophys. Res. Commun. 373 (2008), 555–560.
135. [135] Bernard, Y., Ribeiro, N., Thuaud, F., et al. Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27. PLoS One, 6, 2011, e25302.
136. [136] El-Bakly, W.M., Louka, M.L., El-Halawany, A.M., Schaalan, M.F., 6-Gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation. Cancer Chemother. Pharmacol. 70 (2012), 833–841.
137. [137] Granados-Principal, S., El-azem, N., Pamplona, R., et al. Hydroxytyrosol ameliorates oxidative stress and mitochondrial dysfunction in doxorubicin-induced cardiotoxicity in rats with breast cancer. Biochem. Pharmacol. 90 (2014), 25–33.
138. [138] Xiao, J., Sun, G.-B., Sun, B., et al. Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. Toxicology 292 (2012), 53–62.
139. [139] Kim, D.S., Woo, E.-R., Chae, S.-W., et al. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation. Life Sci. 80 (2007), 314–323.
140. [140] Khan, M., Varadharaj, S., Shobha, J.C., et al. C-phycocyanin ameliorates doxorubicin-induced oxidative stress and apoptosis in adult rat cardiomyocytes. J. Cardiovasc. Pharmacol. 47 (2006), 9–20.
141. [141] Xu, H., Han, Y., Zhang, M., et al. Protective role of Osthole on myocardial cell apoptosis induced by doxorubicin in rats. Int. J. Clin. Exp. Pathol. 8 (2015), 10816–10823.
142. [142] Li, B., Kim, D., Yadav, R., et al. Sulforaphane prevents doxorubicin-induced oxidative stress and cell death in rat H9c2 cells. Int. J. Mol. Med. 36 (2015), 53–64.
143. [143] Singh, P., Sharma, R., McElhanon, K., et al. Sulforaphane protects the heart from doxorubicin-induced toxicity. Free Radic. Biol. Med. 86 (2015), 90–101.
144. [144] Xu, M., Sheng, L., Zhu, X., et al. Protective effect of tetrandrine on doxorubicin-induced cardiotoxicity in rats. Tumori 96 (2010), 460–464.
145. [145] Dai, C.L., Xiong, H.-Y., Tang, L.-F., et al. Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in mice. Cancer Chemother. Pharmacol. 60 (2007), 741–750.
146. [146] Liu, Y., Asnani, A., Zou, L., et al. Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase. Sci. Transl. Med., 6, 2014 266ra170–266ra170.
147. [147] Wang, W.C., Uen, Y.-H., Chang, M.-L., et al. Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro. BMC Complement. Altern. Med., 12, 2012, 1119.
148. [148] Barman, N.R., Kar, P.K., Hazam, P.K., et al. Cardioprotective effect of Urtica parviflora leaf extract against doxorubicin-induced cardiotoxicity in rats. Chin. J. Nat. Med. 11 (2013), 38–42.
149. [149] Mohamad, R.H., El-Bastawesy, A.M., Zekry, Z.K., et al. The role of Curcuma longa against doxorubicin (adriamycin)-induced toxicity in rats. J. Med. Food 12 (2009), 394–402.
150. [150] Choi, E.H., Lee, N., Kim, H.J., et al. Schisandra fructus extract ameliorates doxorubicin-induce cytotoxicity in cardiomyocytes: altered gene expression for detoxification enzymes. Genes Nutr. 2 (2008), 337–345.
151. [151] Liu, L., Shi, R., Shi, Q., et al. Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice. Planta Med. 74 (2008), 203–209.
152. [152] Wang, X., Chen, L., Wang, T., et al. Ginsenoside Rg3 antagonizes adriamycin-induced cardiotoxicity by improving endothelial dysfunction from oxidative stress via upregulating the Nrf2-ARE pathway through the activation of akt. Phytomed. Int. J. Phytother. Phytopharmacol. 22 (2015), 875–884.
153. [153] Yi, S.Y., Nan, K.-J., Chen, S.-J., Effect of extract of Ginkgo biloba on doxorubicin-associated cardiotoxicity in patients with breast cancer. Chin. J. Integr. Traditional Western Med. 28 (2008), 68–70.
154. [154] Panda, S., Kar, A., Periplogenin-3-O–D-Glucopyranosyl-(1→6)–D-Glucopyaranosyl–(1→4)-d-cymaropyranoside, isolated from Aegle marmelos protects doxorubicin induced cardiovascular problems and hepatotoxicity in rats. Cardiovasc. Ther. 27 (2009), 108–116.
155. [155] Agha, A.M., El-Fattah, A.A., Al-Zuhair, H.H., Al-Rikabi, A.C., Chemopreventive effect of Ginkgo biloba extract against benzo(a)pyrene-induced forestomach carcinogenesis in mice: amelioration of doxorubicin cardiotoxicity. J. Exp. Clin. Cancer Res. CR 20 (2001), 39–50.
156. [156] Lv, X., Yu, X., Wang, Y., et al. Berberine Inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression. PLoS One, 7, 2012, e47351.
157. [157] Zhang, H., Shen, W., Gao, C., et al. Protective effects of salidroside on epirubicin-induced early left ventricular regional systolic dysfunction in patients with breast cancer. Drugs R&D 12 (2012), 101–106.
158. [158] Momin, Firoz, Shaikh, Shabina, Khan, Naziya, Rutika Joshi, T.S., Naikwade, N., Cardioprotective effect of Ixora coccinea Linn. flower extract on doxorubicin induced cardiomyopathy in rats. Pharmacologyonline 3 (2011), 1145–1158.
159. [159] Ashour, O.M., Elberry, A.A., Alahdal, A., et al. Protective effect of bilberry (Vaccinium myrtillus) against doxorubicin-induced oxidative cardiotoxicity in rats. Med. Sci. Monit., 17, 2011 BR110-5.
160. [160] Hao, G., Yu, Y., Gu, B., et al. Protective effects of berberine against doxorubicin-induced cardiotoxicity in rats by inhibiting metabolism of doxorubicin. Xenobiotica 45 (2015), 1024–1029.
161. [161] Akbas, H.S., Timur, M., Ozben, T., Concurrent use of antioxidants in cancer therapy: an update. Expert Rev. Clin. Immunol. 2 (2006), 931–939.
162. [162] Miranda-Vilela, A.L., Portilho, F.A., de Araujo, V.G.B., et al. The protective effects of nutritional antioxidant therapy on Ehrlich solid tumor-bearing mice depend on the type of antioxidant therapy chosen: histology, genotoxicity and hematology evaluations. J. Nutr. Biochem. 22 (2011), 1091–1098.
163. [163] Moss, R.W., Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants?. Integr. Cancer Ther. 5 (2006), 63–82.
164. [164] Abushouk, A.I., Negida, A., Ahmed, H., Abdel-Daim, M.M., Neuroprotective mechanisms of plant extracts against MPTP induced neurotoxicity: future applications in Parkinson's disease. Biomed. Pharmacother. 85 (2016), 635–645.